Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Francis Joseph Giles

ORCID:0000-0002-6919-0231

发表论文 1180 篇 · 总被引 58035 次 · h-index 127

代表论文

  • Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial (2024 · Leukemia · 被引 13)
  • Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer (2025 · ESMO Open · 被引 8)
  • Preliminary results from the randomized phase 2 study (1801 part 3B) of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP) versus GnP alone in patients (pts) with previously untreated metastatic pancreatic ductal adenocarcinoma (mPDAC). (2025 · Journal of Clinical Oncology · 被引 5)
  • Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial (2026 · Nature Medicine · 被引 3)
  • Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction (2024 · Translational Oncology · 被引 3)
  • Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study (2024 · Leukemia Research · 被引 3)